We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$4.17M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 86.64%
2 Communication Services 12.99%
3 Industrials 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$23.5M
$85.5M 78.61%
99,113
LVO icon
2
LiveOne
LVO
$68.9M
$14.1M 12.99%
360,294
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$7.96M 7.33%
31,858
SENS icon
4
Senseonics Holdings Inc
SENS
$259M
$761K 0.7%
7,980
FSNN
5
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$399K 0.37%
155,069

Similar funds

Rho Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Rho Capital Partners held 5 positions worth $109M, up 4% from $105M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 80% a quarter earlier, followed by Communication Services and Industrials.

  • Rho Capital Partners's ten largest holdings make up 100% of its $109M portfolio in Q3 2018.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q3 2018.
  • Rho Capital Partners's portfolio value rose 4% quarter-over-quarter to $109M.

Based on Rho Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.